FMP

FMP

Enter

SLS - SELLAS Life Sciences Group, Inc.

Profile of SELLAS Life Sciences Group, Inc.(SLS), SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development

photo-url-https://financialmodelingprep.com/image-stock/SLS.png

SELLAS Life Sciences Group, Inc.

SLS

NASDAQ

1.01 USD

-0.02 (-1.98%)

About

ceo

Dr. Angelos M. Stergiou M.D., ScD h.c.

sector

Healthcare

industry

Biotechnology

website

https://www.sellaslifesciences.com

exchange

NASDAQ

Description

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York.

CIK

0001390478

ISIN

US81642T2096

CUSIP

81642T209

Address

Times Square Tower

Phone

646 200 5278

Country

US

Employee

17

IPO Date

Mar 12, 2008

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep